Kuopio – a centre of pharma and healthtech development?
Erkki Soini from ESiOR participated in a discussion forum organised by Pharma Industry Finland.
Creating Insights
Erkki Soini from ESiOR participated in a discussion forum organised by Pharma Industry Finland.
ESiOR supports Kuopio Health’s goals and strategy.
National FINUSTE2 study assessed ustekinumab treatment patterns and outcomes in Finnish adult patients with Crohn’s disease.
What is hot in Health Economics and Outcomes Research? Check out Virtual ISPOR Europe 2020! ESiOR is on the podium again.
HIMSS & Health 2.0 European Digital Event offers the newest information and solutions of healthcare. HIMSS, Healthcare Information and Management Systems Society, Inc., focuses on
Let us introduce the brand-new ESiOR look! We wanted to refresh the ESiOR look for it to represent who and what we are in the
Cost-effective Intervention for the Prevention of Cardiovascular Events There has not been much evidence on the cost-effectiveness of approved interventions for the prevention of cardiovascular
Due to our business growth, we are looking for an experienced DATA VISUALIZATION EXPERT Your task will be to make social and health economic and
Two of ESiOR’s employees, Senior Consultant Saku Väätäinen and Consultant, Market Access Manager Saara Huoponen, have completed their doctoral studies and received doctoral degrees in
We are happy to welcome Dr. Christian Asseburg – Director, Evidence Generation – and Roope Metsä – Junior Consultant! We are thrilled to have our
Register studies with excellent coverage and deep data are possible in Finland Nationwide noninterventional, retrospective chart review explored real-life characteristics and outcomes of patients with